EBP05
AssetPeptideAlso EnteraBio's Oral Parathyroid Hormone (1-34)
Oral recombinant human parathyroid hormone fragment (1-34) acting as a PTH1R agonist.
- Stage
- Phase 2
- Modality
- Peptide
- Target
- PTH1R
- Indications
- 4
- Trials
- 75
- Developers
- 1
Indications
4Hypoparathyroidism
Phase 2COMPLETEDNCT02152228clinicaltrials.gov7 Oct 2026
Osteoporosis
Phase 2COMPLETEDNCT04003467clinicaltrials.gov7 Oct 2026
Drug safety
Phase 1COMPLETEDNCT02202603clinicaltrials.gov7 Oct 2026
1 more
- Targets and what it contains2
- Owner and partners1
- Trials75
- Evidence for its targets1
- Competitors3
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 5 sources